Regen Biomedical Is A Biomedical Research Company Dedicated To Advancing Regenerative Medicineas A Spin Off Of Regmed Xbit Collaborates With Leading Health Fundscompaniesand Universities Across Europeincluding Maastricht Universitythe Company Focuses On Developing Robust Micro Tissues For Toxicity And Pharmaceutical Screeningwhich Are Essential In Drug Development Regen Biomedical Aims To Enable The Repair And Reconstruction Of Organs And Tissues Through Innovative Cell Therapy Technologiesits Long Term Vision Includes Applications For Repairing Heart Tissuereconstructing Cartilageand Potentially Growing Complex Organs Like Kidneysthe Company Is Part Of A Collaborative Effort Within The Regmed Xb Consortiumworking Alongside Various Partners To Enhance Regenerative Medicine Capabilities In Europe
